Oral Oncology
Volume 36, Issue 1 , Pages 32-36, January 2000

Inhibition of microflora associated with oral malignancy

  • K. Nagy

      Affiliations

    • Department of Dentistry and Oral Surgery, Albert Szent-Györgyi Medical University, Tisza Lajos krt. 64, H-6720 Szeged, Hungary
    • Corresponding Author InformationCorresponding author. Tel.: +36-62-455-299; fax: +36-62-455-282
  • ,
  • I. Szöke

      Affiliations

    • Department of Clinical Microbiology, Albert Szent-Györgyi Medical University, Tisza Lajos krt. 64, H-6720 Szeged, Hungary
  • ,
  • I. Sonkodi

      Affiliations

    • Department of Dentistry and Oral Surgery, Albert Szent-Györgyi Medical University, Tisza Lajos krt. 64, H-6720 Szeged, Hungary
  • ,
  • E. Nagy

      Affiliations

    • Department of Clinical Microbiology, Albert Szent-Györgyi Medical University, Tisza Lajos krt. 64, H-6720 Szeged, Hungary
  • ,
  • A. Mari

      Affiliations

    • Department of Dentistry and Oral Surgery, Albert Szent-Györgyi Medical University, Tisza Lajos krt. 64, H-6720 Szeged, Hungary
  • ,
  • G. Szolnoky

      Affiliations

    • Department of Dermatology, Albert Szent-Györgyi Medical University, Tisza Lajos krt. 64, H-6720 Szeged, Hungary
  • ,
  • H.N. Newman

      Affiliations

    • Clinical Research Centre, Eastman Dental Institute for Oral Health Care Sciences, University of London, London, UK

Received 26 February 1999; accepted 23 March 1999.

Abstract 

Changes in the microflora on oral carcinoma surfaces may lead to both local and systemic infections, which may complicate the morbidity of the patient suffering from oral malignant neoplasms. Thus, anticancer therapy, irradiation, chemotherapy or surgery impairs the defence mechanism of the oral mucosa and is accompanied by proliferation of the mucosal biofilm with overgrowth of yeast and bacteria. This study investigates the inhibition of the biofilm present on the surface of oral squamous cell carcinomas. Biofilm samples were obtained from the central surface (1 cm2) of each lesion in 10 patients (eight male, two female; mean age: 47.6 years; SD ±7.6) before any antibiotherapy or tumour treatment. Patients were randomly divided into two groups and were rinsed with Meridol mouthrinse (amine fluoride) or placebo (saline solution) for 7 days. Samples were repeatedly taken from the same site after rinsing. Samples were transported in pre-reduced brain heart infusion broth and cultured within 1 h of removal, using aerobic and anaerobic complete and selective media. Total aerobic and anaerobic counts were determined and isolated bacteria were identified. The median counts of colony forming units (CFU/ml) after rinsing with Meridol were significantly lower for both aerobes and anaerobes than before rinsing with Meridol. (For aerobes before rinsing: , after rinsing: ; ; for anaerobes before rinsing: , after rinsing: ; . Rinsing with placebo: no significant difference was found. Aerobe median counts before rinsing: , after rinsing: , and for anaerobes: before rinsing , after rinsing: ; [Wilcoxon test].) It was concluded that 7-days (three times a day) Meridol rinsing significantly reduced the surface biofilm of oral carcinoma compared to rinsing with placebo. Clinical examination indicated no irritation of the mucosa. The mouthrinse was well tolerated by the patients, who commented on a reduction in burning sensation and bad breath. Besides routine oral hygiene, rinsing itself could reduce patient morbidity. The findings of the present study indicate that in addition to any other oral focus, the lesion itself, when ulcerated, should receive direct antimicrobial treatment so as to reduce patient morbidity and enhance quality of life.

Keywords:  Oral cancer, Biofilm, Focal infection, Morbidity, Infection control

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(99)00046-9

Oral Oncology
Volume 36, Issue 1 , Pages 32-36, January 2000